Oxibuprocaína

Records for this ingredient, by country (identity only).

ATC S01HA02 · 3 markets · 19 records

Oxibuprocaína 3 markets · 19 records Forms
Filters
MarketCN 12JP 3ES 1
Kind

CN 12 records · 5 shown of 5 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

Only this ingredient

  • 2 mg/0.5 mLliquid倍诺喜奥布卡因Manufacturer: 山东博士伦福瑞达制药有限公司、Manufacturer: 苏州欧康维视生物科技有限公司
  • 75 mg/15 mLliquid爱尔凯因奥布卡因Manufacturer: 合肥立方制药股份有限公司
  • 0.5 % per mL / per unit basis not statedliquidManufacturer: 优尼特尔南京制药有限公司 ×3Manufacturer: 苏州工业园区天龙制药有限公司
  • 80 mg/20 mLliquid倍诺喜奥布卡因
  • 2 mg/0.4 mLliquidManufacturer: 优尼特尔南京制药有限公司 ×3

JP 3 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

Only this ingredient

  • 0.4 %/1 mLophthalmicオキシブプロカイン塩酸塩点眼液0.4%「ニットー」ネオベノール点眼液0.4%、ベノキシール点眼液0.4%

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

Combination products containing this ingredient

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.